MIM
MetLife Investment Management Portfolio holdings
AUM
$17B
1-Year Return
25.61%
This Quarter Return
+15.44%
1 Year Return
+25.61%
3 Year Return
+108.53%
5 Year Return
+194.13%
10 Year Return
–
AUM
$17B
AUM Growth
-$1.5B
(-8.1%)
Cap. Flow
-$3.26B
Cap. Flow
% of AUM
-19.17%
Top 10 Holdings %
Top 10 Hldgs %
26.33%
Holding
2,961
New
180
Increased
949
Reduced
1,091
Closed
240
Top Buys
| 1 |
Coeur Mining
CDE
|
+$25.3M |
| 2 |
Atlantic Union Bankshares
AUB
|
+$18.1M |
| 3 |
Lincoln National
LNC
|
+$15.5M |
| 4 |
Coinbase
COIN
|
+$15.3M |
| 5 |
JBTM
JBT Marel Corporation
JBTM
|
+$14.3M |
Top Sells
| 1 |
Apple
AAPL
|
+$997M |
| 2 |
Amazon
AMZN
|
+$539M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$298M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$254M |
| 5 |
Bank of America
BAC
|
+$71.8M |
Sector Composition
| 1 | Technology | 27.35% |
| 2 | Financials | 13.45% |
| 3 | Industrials | 10.4% |
| 4 | Healthcare | 10.12% |
| 5 | Communication Services | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Vir Biotechnology
VIR
$713M
| $275K | ﹤0.01% |
54,480
| – | – |
|
2002
Arbutus Biopharma
ABUS
$886M
| $274K | ﹤0.01% |
88,766
-121
| -0.1% | -$374 |
|
|
GMRE
2003
Global Medical REIT
GMRE
$511M
| $274K | ﹤0.01% |
39,522
+3,518
| +10% | +$24.4K |
|
2004
South Plains Financial
SPFI
$656M
| $273K | ﹤0.01% |
7,570
+964
| +15% | +$34.7K |
|
2005
Ginkgo Bioworks
DNA
$618M
| $273K | ﹤0.01% |
+24,247
| New | +$273K |
|
2006
Mesa Laboratories
MLAB
$327M
| $272K | ﹤0.01% |
2,888
| – | – |
|
|
FSUN
2007
FirstSun Capital Bancorp Common Stock
FSUN
$1.05B
| $271K | ﹤0.01% |
+7,809
| New | +$271K |
|
2008
Stoke Therapeutics
STOK
$1.31B
| $271K | ﹤0.01% |
23,863
+3,609
| +18% | +$41K |
|
2009
LendingTree
TREE
$977M
| $270K | ﹤0.01% |
7,289
+1,354
| +23% | +$50.2K |
|
2010
Flushing Financial
FFIC
$465M
| $269K | ﹤0.01% |
22,634
+5,975
| +36% | +$71K |
|
2011
York Water
YORW
$440M
| $268K | ﹤0.01% |
8,495
| – | – |
|
2012
Mitek Systems
MITK
$454M
| $267K | ﹤0.01% |
27,018
+4,192
| +18% | +$41.5K |
|
2013
FerroAtlántica
GSM
$780M
| $267K | ﹤0.01% |
+72,803
| New | +$267K |
|
2014
NerdWallet
NRDS
$788M
| $266K | ﹤0.01% |
24,273
+367
| +2% | +$4.03K |
|
2015
Wabash National
WNC
$461M
| $266K | ﹤0.01% |
24,999
-476
| -2% | -$5.06K |
|
2016
Celcuity
CELC
$2.37B
| $265K | ﹤0.01% |
19,872
| – | – |
|
|
NUTX
2017
Nutex Health
NUTX
$462M
| $265K | ﹤0.01% |
+2,129
| New | +$265K |
|
|
BORR
2018
Borr Drilling
BORR
$884M
| $264K | ﹤0.01% |
144,409
| – | – |
|
2019
Monro
MNRO
$507M
| $264K | ﹤0.01% |
17,704
| – | – |
|
2020
Aspen Aerogels
ASPN
$560M
| $264K | ﹤0.01% |
44,577
-719,846
| -94% | -$4.26M |
|
2021
SentinelOne
S
$6.19B
| $264K | ﹤0.01% |
14,426
+7,358
| +104% | +$135K |
|
2022
Keros Therapeutics
KROS
$636M
| $264K | ﹤0.01% |
19,749
+1,651
| +9% | +$22K |
|
2023
Northfield Bancorp
NFBK
$487M
| $263K | ﹤0.01% |
22,946
+1,843
| +9% | +$21.2K |
|
2024
Third Coast Bancshares
TCBX
$546M
| $263K | ﹤0.01% |
8,037
| – | – |
|
2025
Dianthus Therapeutics
DNTH
$1.22B
| $263K | ﹤0.01% |
14,093
| – | – |
|